Literature DB >> 21446568

Preparation, characterization, cytotoxicity and drug release behavior of liposome-enveloped paclitaxel/Fe3O4 nanoparticles.

Min-Jung Kim1, Dae-Hwan Jang, Young-In Lee, Hyun Sook Jung, Hak-Jong Lee, Yong-Ho Choa.   

Abstract

Phospholipid vesicles encapsulating magnetic nanoparticles (liposome complexes) have been prepared for targeting a drug to a specific organ using a magnetic force, as well as for local hyperthermia therapy. Liposome complexes are also an ideal platform for use as contrast agents of magnetic resonance imaging (MRI). We describe the preparation and characterization of liposomes containing magnetite. These liposomes were obtained by thin film hydration method and Fe3O4 nanoparticles were synthesized by coprecipitation method. They were characterized by an electrophoretic light scattering spectrophotometer, the liposome complexes were subsequently coated using chitosan. We have further investigated the ability of the above formulation for drug delivery and MRI applications. We are specifically interested in evaluating our liposome complexes for drug therapy; hence, we selected paclitaxel for the combination study. The amount of paclitaxel was measured at 227 nm using a UV-Vis spectrophotometer. Cytotoxicity of liposome complexes was treated with the various concentrations of paclitaxel in PC3 cell lines. The structure and properties of liposome complexes were analyzed by FT-IR, XRD and VSM. The particle size was analyzed by TEM and DLS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21446568     DOI: 10.1166/jnn.2011.3267

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  6 in total

1.  Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study.

Authors:  Mahdi Karimi; Pinar Avci; Mohsen Ahi; Tarane Gazori; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopharm Drug Deliv       Date:  2013-09-01

2.  Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR).

Authors: 
Journal:  Insights Imaging       Date:  2011-09-29

3.  Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application.

Authors:  Hui Ye; Jiansong Tong; Jiangyi Liu; Wenman Lin; Chengshou Zhang; Kai Chen; Jie Zhao; Wenjing Zhu
Journal:  Oncotarget       Date:  2016-07-12

4.  Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.

Authors:  Hui Ye; Jiansong Tong; Jianzhang Wu; Xia Xu; Shenjie Wu; Botao Tan; Mengjing Shi; Jianguang Wang; Weibo Zhao; Heng Jiang; Sha Jin
Journal:  Int J Nanomedicine       Date:  2014-09-22

5.  Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR).

Authors: 
Journal:  Insights Imaging       Date:  2015-03-13

6.  Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.

Authors:  Rui Yang; Li Y An; Qin F Miao; Feng M Li; Yong Han; Hui X Wang; Dang P Liu; Rong Chen; Sha Q Tang
Journal:  Oncotarget       Date:  2016-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.